Department of Medical Laboratory Sciences, Port Sudan Ahlia College, Port Sudan, Sudan.
Department of Medical Laboratory Sciences, Omdurman Islamic University, Omdurman, Sudan.
Pan Afr Med J. 2020 Dec 10;37:331. doi: 10.11604/pamj.2020.37.331.25180. eCollection 2020.
the outbreak of coronavirus disease 2019 (COVID-19) started in China in December 2019 and spread causing more than 14 million cases all over the world on July 19, 2020. Although, real-time reverse transcription polymerase chain reaction (rRT-PCR) test is the gold standard test, it needs a long time and requires specialized laboratories and highly trained personnel. All these difficulties forced many countries with reduced health resources to limit rRT-PCR tests to individuals with severe symptoms. Thus, routine blood marker that may help physicians to suspect COVID-19 and hence, prioritize patients for molecular diagnosis is badly needed.
fifty-six Sudanese COVID-19 patients admitted to Jabra hospital were included in this study. For all the patients we analyzed complete blood count (CBC), CBC, plasma levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), liver function tests (LFT) and renal function tests (RFT). Statistical analysis was done using SPSS program with a significance level of p≤0.05 and confidence limits (CLs) 95%. The difference between groups was tested using Mann-Whitney test was for quantitative variables while qualitative variables was tested using chi-square (Fisher exact) test.
the result shows that, 35 out of the 56 patients (62.5%) were male and 21 (37.5%) were females with a median age of 60-year-old for both sexes. Lymphocytes % showed decrease to 9.2 (P-value=0.000) and significant increase in neutrophils to 83.05 (P-value=0.005), ESR to 65.54 (P-value=0.000) and CRP to 91.07 (P-value=0.000). The receiver operating characteristic curve (ROC)/area under the curve (AUC) ensured the expellant result of lymphocytes % as a predictor with 92% area under the curve, neutrophils were 90% and ESR 95.8%. The percent of detecting COVID-19 positive RT-PCR (98%) for suspected individuals using ROC showed best cutoff of ≤21.8 for lymphocytes %, ≥67.7 for neutrophils, ≥37.5 for ESR, ≥6.2 for CRP and ≥7.15 for WBCs.
the results also showed that, lymphocyte percentages, neutrophils, CRP and ESR may be used as markers for COVID-19 helping prioritizing individuals for rRT-PCR test.
2019 年 12 月,新型冠状病毒病(COVID-19)在中国爆发,并于 2020 年 7 月 19 日传播至全球,造成超过 1400 万例病例。虽然实时逆转录聚合酶链反应(rRT-PCR)检测是金标准检测,但需要较长时间,且需要专门的实验室和经过高度培训的人员。所有这些困难迫使许多医疗资源减少的国家将 rRT-PCR 检测限制在有严重症状的个体身上。因此,急需一种常规的血液标志物,以帮助医生怀疑 COVID-19 并为患者提供分子诊断。
本研究纳入了 56 例苏丹 COVID-19 患者。对所有患者进行了全血细胞计数(CBC)、C 反应蛋白(CRP)、红细胞沉降率(ESR)、肝功能检查(LFT)和肾功能检查(RFT)分析。采用 SPSS 程序进行统计学分析,显著性水平为 P≤0.05,置信区间(CL)为 95%。使用 Mann-Whitney 检验对定量变量进行组间差异检验,使用卡方检验(Fisher 确切概率法)对定性变量进行检验。
结果显示,56 例患者中,35 例(62.5%)为男性,21 例(37.5%)为女性,男女中位数年龄均为 60 岁。淋巴细胞%下降至 9.2(P 值=0.000),中性粒细胞显著增加至 83.05%(P 值=0.005),ESR 增加至 65.54(P 值=0.000),CRP 增加至 91.07(P 值=0.000)。受试者工作特征曲线(ROC)/曲线下面积(AUC)证实,淋巴细胞%的排斥率作为预测指标,其 AUC 为 92%,中性粒细胞为 90%,ESR 为 95.8%。使用 ROC 对疑似患者进行 COVID-19 阳性 RT-PCR 检测,发现淋巴细胞%的最佳截断值为≤21.8,中性粒细胞≥67.7,ESR≥37.5,CRP≥6.2,白细胞计数≥7.15。
结果还表明,淋巴细胞百分比、中性粒细胞、CRP 和 ESR 可作为 COVID-19 的标志物,有助于优先对患者进行 rRT-PCR 检测。